Annual EBIT
$9.14 B
+$663.00 M+7.82%
December 1, 2024
Summary
- As of February 7, 2025, ABBV annual earnings before interest & taxes is $9.14 billion, with the most recent change of +$663.00 million (+7.82%) on December 1, 2024.
- During the last 3 years, ABBV annual EBIT has fallen by -$6.28 billion (-40.72%).
- ABBV annual EBIT is now -41.83% below its all-time high of $15.71 billion, reached on December 31, 2022.
Performance
ABBV EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$1.49 B
-$4.29 B-153.14%
December 1, 2024
Summary
- As of February 7, 2025, ABBV quarterly earnings before interest & taxes is -$1.49 billion, with the most recent change of -$4.29 billion (-153.14%) on December 1, 2024.
- Over the past year, ABBV quarterly EBIT has dropped by -$4.29 billion (-153.14%).
- ABBV quarterly EBIT is now -127.20% below its all-time high of $5.48 billion, reached on March 31, 2022.
Performance
ABBV Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
$6.60 B
-$3.27 B-33.10%
December 1, 2024
Summary
- As of February 7, 2025, ABBV TTM earnings before interest & taxes is $6.60 billion, with the most recent change of -$3.27 billion (-33.10%) on December 1, 2024.
- Over the past year, ABBV TTM EBIT has dropped by -$3.27 billion (-33.10%).
- ABBV TTM EBIT is now -61.23% below its all-time high of $17.03 billion, reached on September 30, 2022.
Performance
ABBV TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ABBV EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.8% | -153.1% | -33.1% |
| 3 y3 years | -40.7% | -185.7% | -59.6% |
| 5 y5 years | -10.5% | -141.0% | -35.4% |
ABBV EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -41.8% | +7.8% | -127.2% | at low | -61.2% | at low |
| 5 y | 5-year | -41.8% | +56.1% | -127.2% | at low | -61.2% | +12.8% |
| alltime | all time | -41.8% | +226.6% | -127.2% | +25.2% | -61.2% | +614.1% |
AbbVie EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $9.14 B(+7.8%) | -$1.49 B(-153.1%) | $6.60 B(-33.1%) |
| Sep 2024 | - | $2.80 B(-2.4%) | $9.87 B(+3.1%) |
| Jun 2024 | - | $2.87 B(+18.9%) | $9.57 B(-2.9%) |
| Mar 2024 | - | $2.42 B(+36.0%) | $9.86 B(+16.4%) |
| Dec 2023 | $8.47 B(-46.0%) | $1.78 B(-29.2%) | $8.47 B(-17.2%) |
| Sep 2023 | - | $2.51 B(-20.7%) | $10.23 B(-19.3%) |
| Jun 2023 | - | $3.16 B(+207.6%) | $12.68 B(+12.6%) |
| Mar 2023 | - | $1.03 B(-70.9%) | $11.26 B(-28.3%) |
| Dec 2022 | $15.71 B(+1.9%) | $3.53 B(-28.8%) | $15.71 B(-7.8%) |
| Sep 2022 | - | $4.96 B(+185.2%) | $17.03 B(+4.1%) |
| Jun 2022 | - | $1.74 B(-68.2%) | $16.35 B(-0.2%) |
| Mar 2022 | - | $5.48 B(+12.9%) | $16.39 B(+6.3%) |
| Dec 2021 | $15.41 B(+163.4%) | $4.85 B(+13.2%) | $15.41 B(+59.2%) |
| Sep 2021 | - | $4.28 B(+140.9%) | $9.68 B(+13.5%) |
| Jun 2021 | - | $1.78 B(-60.5%) | $8.53 B(+27.5%) |
| Mar 2021 | - | $4.50 B(-612.4%) | $6.69 B(+14.3%) |
| Dec 2020 | $5.85 B(-42.7%) | -$878.00 M(-128.1%) | $5.85 B(-43.5%) |
| Sep 2020 | - | $3.13 B(-5231.1%) | $10.36 B(+6.7%) |
| Jun 2020 | - | -$61.00 M(-101.7%) | $9.71 B(-11.2%) |
| Mar 2020 | - | $3.66 B(+0.8%) | $10.94 B(+7.1%) |
| Dec 2019 | $10.21 B(+56.0%) | $3.63 B(+46.4%) | $10.21 B(+122.7%) |
| Sep 2019 | - | $2.48 B(+113.0%) | $4.58 B(-11.9%) |
| Jun 2019 | - | $1.17 B(-60.3%) | $5.20 B(-18.3%) |
| Mar 2019 | - | $2.93 B(-247.1%) | $6.37 B(-2.7%) |
| Dec 2018 | $6.54 B(-26.3%) | -$1.99 B(-164.3%) | $6.54 B(-34.7%) |
| Sep 2018 | - | $3.10 B(+32.9%) | $10.03 B(+7.6%) |
| Jun 2018 | - | $2.33 B(-24.9%) | $9.32 B(-3.2%) |
| Mar 2018 | - | $3.11 B(+108.2%) | $9.62 B(+8.4%) |
| Dec 2017 | $8.88 B | $1.49 B(-37.5%) | $8.88 B(-8.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | $2.39 B(-9.4%) | $9.70 B(+1.1%) |
| Jun 2017 | - | $2.64 B(+11.8%) | $9.60 B(+3.2%) |
| Mar 2017 | - | $2.36 B(+1.9%) | $9.30 B(+4.1%) |
| Dec 2016 | $8.93 B(+21.3%) | $2.31 B(+1.3%) | $8.93 B(+2.1%) |
| Sep 2016 | - | $2.29 B(-2.4%) | $8.75 B(+5.2%) |
| Jun 2016 | - | $2.34 B(+17.6%) | $8.32 B(+6.3%) |
| Mar 2016 | - | $1.99 B(-6.6%) | $7.83 B(+6.3%) |
| Dec 2015 | $7.36 B(+163.2%) | $2.13 B(+15.0%) | $7.36 B(+69.9%) |
| Sep 2015 | - | $1.85 B(+0.2%) | $4.33 B(+30.7%) |
| Jun 2015 | - | $1.85 B(+21.1%) | $3.31 B(+11.6%) |
| Mar 2015 | - | $1.53 B(-270.2%) | $2.97 B(+6.1%) |
| Dec 2014 | $2.80 B(-50.3%) | -$898.00 M(-207.5%) | $2.80 B(-46.3%) |
| Sep 2014 | - | $835.00 M(-44.6%) | $5.21 B(-9.2%) |
| Jun 2014 | - | $1.51 B(+11.1%) | $5.74 B(+1.0%) |
| Mar 2014 | - | $1.36 B(-10.4%) | $5.68 B(+0.8%) |
| Dec 2013 | $5.63 B(-3.4%) | $1.51 B(+11.2%) | $5.63 B(-5.0%) |
| Sep 2013 | - | $1.36 B(-5.9%) | $5.93 B(-4.1%) |
| Jun 2013 | - | $1.45 B(+10.4%) | $6.18 B(+0.7%) |
| Mar 2013 | - | $1.31 B(-27.4%) | $6.13 B(+5.2%) |
| Dec 2012 | $5.83 B(+58.9%) | $1.81 B(+12.0%) | $5.83 B(+12.6%) |
| Sep 2012 | - | $1.61 B(+15.1%) | $5.18 B(+43.2%) |
| Jun 2012 | - | $1.40 B(+39.4%) | $3.62 B(-3.6%) |
| Mar 2012 | - | $1.01 B(-12.8%) | $3.75 B(+2.2%) |
| Dec 2011 | $3.67 B(-24.2%) | $1.15 B(+2051.7%) | $3.67 B(+45.9%) |
| Sep 2011 | - | $53.61 M(-96.5%) | $2.51 B(+2.2%) |
| Jun 2011 | - | $1.54 B(+66.2%) | $2.46 B(+166.2%) |
| Mar 2011 | - | $924.44 M | $924.44 M |
| Dec 2010 | $4.84 B(-5.2%) | - | - |
| Dec 2009 | $5.10 B | - | - |
FAQ
- What is AbbVie annual earnings before interest & taxes?
- What is the all time high annual EBIT for AbbVie?
- What is AbbVie annual EBIT year-on-year change?
- What is AbbVie quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for AbbVie?
- What is AbbVie quarterly EBIT year-on-year change?
- What is AbbVie TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for AbbVie?
- What is AbbVie TTM EBIT year-on-year change?
What is AbbVie annual earnings before interest & taxes?
The current annual EBIT of ABBV is $9.14 B
What is the all time high annual EBIT for AbbVie?
AbbVie all-time high annual earnings before interest & taxes is $15.71 B
What is AbbVie annual EBIT year-on-year change?
Over the past year, ABBV annual earnings before interest & taxes has changed by +$663.00 M (+7.82%)
What is AbbVie quarterly earnings before interest & taxes?
The current quarterly EBIT of ABBV is -$1.49 B
What is the all time high quarterly EBIT for AbbVie?
AbbVie all-time high quarterly earnings before interest & taxes is $5.48 B
What is AbbVie quarterly EBIT year-on-year change?
Over the past year, ABBV quarterly earnings before interest & taxes has changed by -$4.29 B (-153.14%)
What is AbbVie TTM earnings before interest & taxes?
The current TTM EBIT of ABBV is $6.60 B
What is the all time high TTM EBIT for AbbVie?
AbbVie all-time high TTM earnings before interest & taxes is $17.03 B
What is AbbVie TTM EBIT year-on-year change?
Over the past year, ABBV TTM earnings before interest & taxes has changed by -$3.27 B (-33.10%)